# FDA Inspection 1241064 - Hospira Inc - June 07, 2024

Source: https://www.keypedia.com/records/fda_inspections/hospira-inc/251b750d-e7dd-4072-b32a-338d73b69de8
Source feed: FDA_Inspections

> FDA Inspection 1241064 for Hospira Inc on June 07, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241064
- Company Name: Hospira Inc
- Inspection Date: 2024-06-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1278254 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/hospira-inc/6c00eee8-fc0b-4ab1-aaba-e8deb98be2c9)
- [FDA Inspection 1278254 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/hospira-inc/7e6002bd-1894-4b68-9ed6-33af9016d435)
- [FDA Inspection 1121881 - 2020-02-27](https://www.keypedia.com/records/fda_inspections/hospira-inc/f3e69bc7-7da1-430b-adf1-b300d220b745)
- [FDA Inspection 919379 - 2015-04-13](https://www.keypedia.com/records/fda_inspections/hospira-inc/8de579f0-ec4d-4c3e-a747-19427cacb07f)
- [FDA Inspection 906256 - 2014-12-09](https://www.keypedia.com/records/fda_inspections/hospira-inc/a17c2ddd-40bf-4d92-b42b-1d2b5a480000)

Company: https://www.keypedia.com/companies/hospira-inc/289dd5d3-2a33-49a2-bcf1-61d983a83d50

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d